WallStreetZenWallStreetZen

NASDAQ: CELZ
Creative Medical Technology Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CELZ past revenue growth

How has CELZ's revenue growth performed historically?
Company
-89.84%
Industry
153.85%
Market
17.91%
CELZ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CELZ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CELZ's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CELZ earnings and revenue history

Current Revenue
$9.0k
Current Earnings
-$5.3M
Current Profit Margin
-58,739.7%

CELZ Return on Equity

Current Company
-41.5%
Current Industry
-63.5%
Current Market
188%
CELZ's Return on Equity (-41.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CELZ announces earnings.

CELZ Return on Assets

Current Company
-40.2%
Current Industry
2.9%
CELZ is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CELZ Return on Capital Employed

Current Company
-51.11%
Current Industry
19.5%
CELZ's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CELZ vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CELZ$9.00k-$5.19M-$5.29M-40.86%N/A
TENX$0.00-$7.68M-$7.71MN/AN/A
TRVN$3.13M-$35.99M-$40.29M-11.43%N/A
IBIO$50.00k-$25.95M-$27.28M-43.46%N/A
EFTR$0.00-$32.78M-$35.81M-100.00%N/A
View Top Biotech Stocks

CELZ earnings dates

Next earnings date
May 10, 2024

Creative Medical Technology Holdings Earnings & Revenue FAQ

What were CELZ's earnings last quarter?

On Invalid Date, Creative Medical Technology Holdings (NASDAQ: CELZ) reported Q4 2023 earnings per share (EPS) of -$1.21, up 77.17% year over year. Total Creative Medical Technology Holdings earnings for the quarter were -$1.68 million. In the same quarter last year, Creative Medical Technology Holdings's earnings per share (EPS) was -$5.30.

If you're new to stock investing, here's how to buy Creative Medical Technology Holdings stock.

What was CELZ's earnings growth in the past year?

As of Q2 2024, Creative Medical Technology Holdings's earnings has grown year over year. Creative Medical Technology Holdings's earnings in the past year totalled -$5.29 million.

What is CELZ's earnings date?

Creative Medical Technology Holdings's earnings date is Invalid Date. Add CELZ to your watchlist to be reminded of CELZ's next earnings announcement.

What was CELZ's revenue last quarter?

On Invalid Date, Creative Medical Technology Holdings (NASDAQ: CELZ) reported Q4 2023 revenue of $3.00 thousand up 83.87% year over year. In the same quarter last year, Creative Medical Technology Holdings's revenue was $18.60 thousand.

What was CELZ's revenue growth in the past year?

As of Q2 2024, Creative Medical Technology Holdings's revenue has grown -89.84% year over year. This is 243.69 percentage points lower than the US Biotechnology industry revenue growth rate of 153.85%. Creative Medical Technology Holdings's revenue in the past year totalled $9.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.